Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010)
Stryker (SYK) reported Curent Deferred Tax Liability of $26.9 million for Q4 2010, up 11.62% year-over-year from $24.1 million in Q4 2009, and up 11.62% on a QoQ basis from $24.1 million in Q4 2009.
Stryker (SYK) has 2 years of Curent Deferred Tax Liability data on file, last reported at $26.9 million in Q4 2010.
- Quarterly Curent Deferred Tax Liability rose 11.62% year-over-year to $26.9 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $26.9 million (up 11.62% YoY) and the FY2010 annual result came in at $26.9 million, up 11.62% from the prior year.
- Curent Deferred Tax Liability rose to $26.9 million in Q4 2010 per SYK's latest filing, from $24.1 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $26.9 million in Q4 2010 and bottomed at $24.1 million in Q4 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 26.90 Mn |
| Dec 31, 2010 | 26.90 Mn |
| Dec 31, 2009 | 24.10 Mn |
| Dec 31, 2009 | 24.10 Mn |